1.35 TWD
6.43 M TWD
172.47 M TWD
About RBC BIOSCIENCE CORPORATION
Sector
Industry
CEO
Ming Wei Zhuo
Website
Headquarters
New TaiPei
Founded
2006
ISIN
TW0006848005
FIGI
BBG0132GD3Q5
RBC Bioscience Corp. manufactures reagents and devices for life science and molecular diagnosis. Its products include real genomics, MagCore automated nudeic acid extractor and nudeic acid extraction kits, HIT competent cells, polymerases, cloning systems and DNA ladders. The company was founded on February 7, 2006 and is headquartered in New Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6848 is 18.70 TWD — it has increased by 2.75% in the past 24 hours. Watch RBC BIOSCIENCE CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange RBC BIOSCIENCE CORPORATION stocks are traded under the ticker 6848.
6848 stock has risen by 3.60% compared to the previous week, the month change is a −6.97% fall, over the last year RBC BIOSCIENCE CORPORATION has showed a 16.87% increase.
6848 reached its all-time high on Oct 25, 2021 with the price of 56.00 TWD, and its all-time low was 13.45 TWD and was reached on Feb 9, 2023. View more price dynamics on 6848 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6848 stock is 2.74% volatile and has beta coefficient of 0.39. Track RBC BIOSCIENCE CORPORATION stock price on the chart and check out the list of the most volatile stocks — is RBC BIOSCIENCE CORPORATION there?
Yes, you can track RBC BIOSCIENCE CORPORATION financials in yearly and quarterly reports right on TradingView.
6848 net income for the last half-year is 13.14 M TWD, while the previous report showed 4.12 M TWD of net income which accounts for 218.72% change. Track more RBC BIOSCIENCE CORPORATION financial stats to get the full picture.
RBC BIOSCIENCE CORPORATION dividend yield was 2.72% in 2023, and payout ratio reached 88.80%. The year before the numbers were 7.07% and 384.62% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 53.00 employees. See our rating of the largest employees — is RBC BIOSCIENCE CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RBC BIOSCIENCE CORPORATION EBITDA is 47.61 M TWD, and current EBITDA margin is 19.26%. See more stats in RBC BIOSCIENCE CORPORATION financial statements.
Like other stocks, 6848 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RBC BIOSCIENCE CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RBC BIOSCIENCE CORPORATION technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RBC BIOSCIENCE CORPORATION stock shows the buy signal. See more of RBC BIOSCIENCE CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.